News

Monday, September 14, 2020

COVID-19 Vaccine Trial Begins at the University of Maryland School of Medicine

Researchers at the University of Maryland School of Medicine (UMSOM) have begun participation in the Phase 3 clinical trial of an investigational COVID-19 vaccine co-developed by scientists at Moderna Inc. and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This clinical trial is a key step toward final approval of a vaccine to protect against the SARS-CoV-2 coronavirus that has impacted millions of people around the world.


MORE NEWS >>

Leave a Reply

Your email address will not be published. Required fields are marked *